Inducing mucosal IgA: a challenge for vaccine adjuvants and delivery systems

PN Boyaka - The Journal of Immunology, 2017 - journals.aai.org
Abstract Mucosal IgA or secretory IgA (SIgA) are structurally equipped to resist chemical
degradation in the harsh environment of mucosal surfaces and enzymes of host or microbial …

The vaginal microbiota, bacterial biofilms and polymeric drug-releasing vaginal rings

L Carson, R Merkatz, E Martinelli, P Boyd, B Variano… - Pharmaceutics, 2021 - mdpi.com
The diversity and dynamics of the microbial species populating the human vagina are
increasingly understood to play a pivotal role in vaginal health. However, our knowledge …

[HTML][HTML] Vaginal rings with exposed cores for sustained delivery of the HIV CCR5 inhibitor 5P12-RANTES

JW McBride, P Boyd, N Dias, D Cameron… - Journal of Controlled …, 2019 - Elsevier
Antiretroviral-releasing vaginal rings are at the forefront of ongoing efforts to develop
microbicide-based strategies for prevention of heterosexual transmission of the human …

Fused deposition modeling three-dimensional printing of flexible polyurethane intravaginal rings with controlled tunable release profiles for multiple active drugs

Y Chen, YL Traore, L Walker, S Yang, EA Ho - Drug Delivery and …, 2022 - Springer
We designed and engineered novel intravaginal ring (IVR) medical devices via fused
deposition modeling (FDM) three-dimensional (3D) printing for controlled delivery of …

Needle-free immunization with chitosan-based systems

B Singh, S Maharjan, P Sindurakar, KH Cho… - International Journal of …, 2018 - mdpi.com
Despite successful use, needle-based immunizations have several issues such as the risk of
injuries and infections from the reuse of needles and syringes and the low patient …

IL-7-adjuvanted vaginal vaccine elicits strong mucosal immune responses in non-human primates

S Logerot, S Figueiredo-Morgado… - Frontiers in …, 2021 - frontiersin.org
Mucosal immune responses are crucial in protecting against pathogens entering through
mucosal surfaces. However, due to poor T-cell responsiveness upon mucosal antigenic …

In vitro release testing methods for drug-releasing vaginal rings

P Boyd, B Variano, P Spence, CF McCoy… - Journal of Controlled …, 2019 - Elsevier
Drug-releasing vaginal rings are torus-shaped devices, generally fabricated from
thermoplastic polymers or silicone elastomers, used to administer pharmaceutical drugs to …

Mucosal vaccine approaches for prevention of HIV and SIV transmission

PA Kozlowski, A Aldovini - Current immunology reviews, 2019 - ingentaconnect.com
Optimal protective immunity to HIV will likely require that plasma cells, memory B cells and
memory T cells be stationed in mucosal tissues at portals of viral entry. Mucosal vaccine …

Vaginal delivery of vaccines

HM VanBenschoten, KA Woodrow - Advanced drug delivery reviews, 2021 - Elsevier
Recent estimates suggest that one in two sexually active individuals will acquire a sexually
transmitted infection by age 25, an alarming statistic that amounts to over 1 million new …

Pharmaceutical approaches to HIV treatment and prevention

B Yavuz, JL Morgan, L Showalter… - Advanced …, 2018 - Wiley Online Library
Human immunodeficiency virus (HIV) infection continues to pose a major infectious disease
threat worldwide. It is characterized by the depletion of CD4+ T cells, persistent immune …